Marcelo Goyanes participates in the 6th International Fashion Law Congress of the Brazilian Bar Association – OAB/RJ.
Marcelo Goyanes will join the triathlete Fernanda Keller and Edoardo Belleza, leader of clothing category at Specialized Bikes Brasil, in a webinar that will address how the improvements in clothing affects the performance of athletes and how this technology applied to products can be protected by Intellectual Property law. The panel is part of the (...)
Read more
Murta Goyanes Advogados in The Legal 500 ranking.
Once again, Murta Goyanes Advogados was recognized by the international ranking The Legal 500, in the Latin America 2022 edition, for its performance in Intellectual Property. Our firm was listed among the main practitioners in Brazil and its partners were recognized for the excellence of their services. According to the publication, Murta Goyanes Advogados is ‘able to efficiently and expertly (...)
Read more
BPTO’s operation on November 1 and 2, 2021 and extension of deadlines.
The Brazilian Patent and Trademark Office (BPTO) will be closed on November 1 and 2, 2021. The deadlines expiring on these dates will be automaticaly extended to November 3, 2021.
Read more
Federal Government enacts Law No. 14,200 with new rules for compulsory license of patents.
On September 2, 2021, the Federal Government enacted Law No. 14,200, which amends Law No. 9,279/96 – the Brazilian Industrial Property Law (BIPL), as to compulsory licensing in cases of national or international emergency, and in case of public interest or recognition of public calamity nationwide. The compulsory licenses will be made on a case-by-case basis upon (a) payment of an indemnity to (...)
Read more
Lawyers of Murta Goyanes are recognized by WWL Copyrights.
We are pleased to announce that our attorneys Antonio Murta Filho, Marcelo Goyanes, Luiza Duarte, Íris Sá and Tatiana Suschko have been recognized by the WWL Copyrights 2021 ranking.
Read more
BPTO informs the new proceedings for prosecution of pharmaceutical patent applications after extinction of ANVISA’s prior approval.
On August 31, 2021, the Brazilian Patent and Trademark Office (BPTO) published information on its website concerning the prosecution of pharmaceutical patent applications after extinction of the Brazilian Health Surveillance Agency (ANVISA)’s prior approval. We would like to point out the following:  i.  the exchange of patent applications between both institutions was ended on August 27, 2021; ii.  patent applications with examination already (...)
Read more
ANVISA’s prior approval on pharmaceutical patent applications is no longer required.
On August 26, 2021, Law No. 14,195 was published and revoked the sole paragraph of Article 40 and Article 229-C of Law No. 9,279/1996 (the Brazilian Industrial Property Law – BIPL). The sole paragraph of Article 40, which was recently declared unconstitutional by the Supreme Federal Court, extended the term of validity of patents of invention whose applications took more than 10 years to be examined (...)
Read more
BPTO updates proceedings for entering into the Brazilian national phase of PCT applications.
On August 24, 2021, the Brazilian Patent and Trademark Office (BPTO) published Ordinance No. 39, which updates proceedings for entering into the Brazilian national phase of PCT patent applications and, therefore, replaces Resolutions Nos. 77/2013 and 179/2017. The Ordinance No. 39 stablishes a significant change over the former resolutions as to the following points: (i) (...)
Read more